Welcome to our dedicated page for Flowserve SEC filings (Ticker: FLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Flowserve Corporation (NYSE: FLS) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Flowserve, a New York corporation listed on the New York Stock Exchange, uses current reports on Form 8-K and other filings to communicate material events related to its fluid motion and flow control business, which includes engineered pumps, valves, seals and flow management services.
In its Form 8-K filings, Flowserve reports a range of topics, such as results of operations and financial condition, leadership and board changes, and significant transactions. For example, the company has filed 8-Ks announcing quarterly financial results, including bookings, sales, margins and adjusted earnings per share, as well as updates on its guidance. Other 8-Ks describe the appointment or departure of certain officers, changes in board composition and related compensatory arrangements.
Flowserve’s filings also document strategic corporate actions. The company filed an 8-K detailing the mutual termination of a merger agreement with Chart Industries, Inc., including the receipt of a cash termination fee and reimbursement of expenses. Additional 8-Ks describe the entry into, and completion of, a transaction to divest BW/IP – New Mexico, Inc., the subsidiary holding its legacy asbestos liabilities and related insurance assets, and explain how those liabilities and assets are removed from its consolidated balance sheet.
Investors can use these filings to understand Flowserve’s exposure to risks and uncertainties, as the company includes extensive forward-looking statements and risk factor summaries in its 8-K disclosures. These sections discuss issues such as supply chain disruptions, dependence on energy, chemical and power generation markets, international regulatory risks, litigation, foreign currency exposure, environmental obligations and information technology and cybersecurity considerations.
On Stock Titan, AI-powered tools can help interpret complex Flowserve filings by summarizing key points from Forms 8-K and highlighting material developments in areas like capital allocation, acquisitions and divestitures, leadership changes and risk disclosures. Real-time updates from EDGAR, combined with AI-generated overviews, allow users to quickly see how new filings may affect their view of Flowserve’s operations and financial profile.
A holder of Common Stock in the issuer of symbol FLS has filed a notice under Rule 144 to sell up to 7,663 shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 686,528. The issuer had 127,115,509 shares outstanding. These shares were originally acquired as compensation in two grants on 05/25/2024 and 05/16/2025.
Flowserve Corporation describes a global flow-control business built around two segments: the Pumps Division and Flow Control Division. The company serves energy, chemical, power generation and general industries with pumps, valves, seals, automation and aftermarket services supported by 126 pump QRCs and 26 valve QRCs worldwide.
Bookings were $4.7 billion in 2025, matching 2024 and up from $4.3 billion in 2023, with 2025 mix of 34% general industries, 33% energy, 19% chemical and 14% power generation. Total backlog at December 31 2025 was $2.9 billion, including $2,044.8 million in Pumps and $828.6 million in Flow Control.
The company emphasizes its "3D Strategy" of diversification, decarbonization and digitization, including its RedRaven IIoT platform and Energy Advantage Program to support customers’ energy transition and asset health. Flowserve employs about 16,000 associates in more than 48 countries and highlights seasonality, raw-material inflation, cybersecurity, geopolitical exposure and extensive environmental, regulatory and international risks that could affect demand, margins and cash flow.
Flowserve Corporation insider Kenneth Siegel has filed a notice to sell 3,229 shares of Flowserve common stock under SEC Rule 144. The planned sale, through Merrill Lynch on the NYSE, has an aggregate market value of $288,801.76 at the time of the notice.
The shares were acquired on May 12, 2023 as employee stock in a compensatory transaction. Flowserve had 127,030,052 shares of common stock outstanding, providing context for the relative size of this proposed insider sale.
Flowserve Corporation director John L. Garrison Jr. reported an acquisition of phantom stock on 02/11/2026 under the company’s deferred compensation plan. He received 839 shares of phantom stock at $87.37 per share, which increased his directly owned phantom stock balance to 37,041 shares.
Each phantom stock share is the economic equivalent of one share of Flowserve common stock and represents deferred director compensation. These phantom shares become payable in common stock when he terminates service as a member of Flowserve’s board of directors.
Flowserve Corporation director Ruby R. Chandy reported an acquisition of phantom stock as part of board compensation. On February 11, 2026, she received 69 units of phantom stock at an indicated value of $87.37 per unit, bringing her total directly held phantom stock to 33,193 units.
Each phantom stock unit is the economic equivalent of one share of Flowserve common stock and reflects director fees deferred under the company’s deferred compensation plan. These phantom stock units will be paid out in shares of common stock when she ceases serving on the board.
Flowserve director Cheryl H. Johnson was granted 345 shares of phantom stock on 02/11/2026 as part of her director compensation. Each phantom stock share is economically equivalent to one share of Flowserve common stock and is issued under the company’s deferred compensation plan.
After this award, Johnson beneficially owns 11,233 phantom stock shares directly. These phantom shares will be paid out in Flowserve common stock when she terminates her service on the company’s board of directors, aligning her compensation with long-term shareholder value.
Flowserve Corporation has agreed to acquire Trillium Flow Technologies’ Valves Division for $490 million in cash, adding a market-leading portfolio of highly engineered, mission-critical valves used in nuclear and traditional power generation, industrial, and critical infrastructure applications.
The deal is expected to close in mid-2026, funded through a combination of cash on hand and additional debt, and remains subject to customary closing conditions and regulatory approvals. Flowserve also released a press release and investor presentation covering its fourth-quarter and full-year 2025 financial and operating results.
Flowserve Corporation’s President and CEO, Robert Scott Rowe, reported a small share purchase through a company stock plan. On February 2, 2026, he acquired 84 shares of common stock at $78.15 per share under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in a prescheduled transaction.
Following this transaction, Rowe directly owned 346,714 Flowserve common shares, reflecting his ongoing equity stake as both a director and senior executive.
Flowserve Corporation reported that board member Kenneth I. Siegel has told the Board he will not stand for re-election at the company’s 2026 annual meeting of shareholders. He will continue to serve as a director until that meeting, providing continuity through the upcoming governance cycle. The company stated that Mr. Siegel’s decision was not the result of any disagreement with management or the Board, indicating this is a planned transition rather than a dispute-driven departure.
Flowserve Corporation has completed the divestiture of all its legacy asbestos liabilities by selling its wholly owned subsidiary BW/IP – New Mexico, Inc. to Ajax HoldCo LLC, an affiliate of Acorn Investment Partners and a portfolio company of Oaktree Capital Management. At closing, BWIP was capitalized with related assets and approximately $219,000,000 in cash, including a $199,000,000 contribution from Flowserve and a $20,000,000 contribution from the buyer.
After this transaction, the asbestos-related liabilities and associated insurance assets will be removed from Flowserve’s consolidated balance sheet, while the buyer assumes management of BWIP, including claims and insurance reimbursements. The boards of the selling entities received an independent solvency opinion supporting their determination that BWIP was solvent and adequately capitalized after the divestiture.